MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Clinical trials for MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with severe gut disease: drug trial launches
Disease control Recruiting nowThis study tests a new medicine called afimkibart in children aged 2 to 17 with moderate to severe ulcerative colitis, a disease that causes inflammation and sores in the colon. The goal is to see if the drug can safely help children feel better and achieve remission (no symptoms…
Matched conditions: MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for ulcerative colitis: phase 3 trial launches
Disease control Recruiting nowThis study tests a new drug called RO7790121 for people with moderate to severe ulcerative colitis, a condition that causes inflammation in the colon. About 350 adults who haven't responded well to other treatments will receive either the drug or a placebo. The main goal is to se…
Matched conditions: MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC